Lakeland Industries, Inc. (NASDAQ:LAKE – Free Report) – Stock analysts at Roth Capital lifted their Q3 2026 EPS estimates for Lakeland Industries in a note issued to investors on Tuesday, September 16th. Roth Capital analyst G. Sweeney now forecasts that the medical instruments supplier will earn $0.19 per share for the quarter, up from their prior estimate of $0.18. The consensus estimate for Lakeland Industries’ current full-year earnings is $0.48 per share. Roth Capital also issued estimates for Lakeland Industries’ Q4 2026 earnings at $0.29 EPS and FY2027 earnings at $1.28 EPS.
Several other research analysts also recently issued reports on LAKE. DA Davidson dropped their target price on shares of Lakeland Industries from $23.00 to $20.00 and set a “buy” rating on the stock in a research note on Thursday, September 11th. Lake Street Capital set a $26.00 target price on shares of Lakeland Industries and gave the stock a “buy” rating in a research note on Tuesday, June 10th. Zacks Research upgraded shares of Lakeland Industries from a “strong sell” rating to a “hold” rating in a research note on Thursday, August 14th. Finally, Wall Street Zen upgraded shares of Lakeland Industries from a “sell” rating to a “hold” rating in a research note on Saturday, September 13th. Three equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $25.00.
Lakeland Industries Trading Up 2.1%
Shares of NASDAQ LAKE opened at $14.87 on Thursday. The firm’s 50 day moving average price is $14.58 and its 200-day moving average price is $16.31. The company has a market cap of $142.31 million, a PE ratio of -5.43 and a beta of 1.11. Lakeland Industries has a 52-week low of $12.76 and a 52-week high of $27.28. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.41 and a current ratio of 3.66.
Lakeland Industries (NASDAQ:LAKE – Get Free Report) last announced its quarterly earnings data on Tuesday, September 9th. The medical instruments supplier reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.40. The business had revenue of $52.50 million for the quarter, compared to analysts’ expectations of $54.59 million. Lakeland Industries had a negative net margin of 11.22% and a negative return on equity of 3.07%. Lakeland Industries has set its FY 2026 guidance at EPS.
Lakeland Industries Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 22nd. Investors of record on Friday, August 15th were given a dividend of $0.03 per share. The ex-dividend date was Friday, August 15th. This represents a $0.12 dividend on an annualized basis and a yield of 0.8%. Lakeland Industries’s dividend payout ratio is -4.38%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Royce & Associates LP lifted its position in Lakeland Industries by 9.4% during the first quarter. Royce & Associates LP now owns 931,920 shares of the medical instruments supplier’s stock valued at $18,927,000 after purchasing an additional 79,940 shares during the period. Pacific Ridge Capital Partners LLC raised its position in Lakeland Industries by 3.8% in the first quarter. Pacific Ridge Capital Partners LLC now owns 297,962 shares of the medical instruments supplier’s stock worth $6,052,000 after acquiring an additional 10,992 shares during the period. First Eagle Investment Management LLC raised its position in Lakeland Industries by 27.3% in the second quarter. First Eagle Investment Management LLC now owns 278,756 shares of the medical instruments supplier’s stock worth $3,794,000 after acquiring an additional 59,803 shares during the period. Ancora Advisors LLC raised its position in Lakeland Industries by 85.1% in the first quarter. Ancora Advisors LLC now owns 276,688 shares of the medical instruments supplier’s stock worth $5,620,000 after acquiring an additional 127,195 shares during the period. Finally, Geode Capital Management LLC raised its position in Lakeland Industries by 115.9% in the second quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after acquiring an additional 116,901 shares during the period. Institutional investors own 71.69% of the company’s stock.
Lakeland Industries Company Profile
Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.
Read More
- Five stocks we like better than Lakeland Industries
- How Technical Indicators Can Help You Find Oversold StocksĀ
- Why Seagate Is Wall Street’s New Favorite AI Infrastructure Play
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 AI Infrastructure Stocks With Upside After the Summer Rally
- Manufacturing Stocks Investing
- Can Advantage2 Help Overcome D-Wave’s Share Price Plateau?
Receive News & Ratings for Lakeland Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeland Industries and related companies with MarketBeat.com's FREE daily email newsletter.